secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2026-07-06T20:06:28+00:00
Accession:  0001193125-26-296174
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences shareholders approve doubling authorized common shares to 300M
--------------------------------------------------------------------------------

- Shareholders approved Certificate of Amendment increasing authorized common shares from 150M to 300M.
- All nine director nominees elected, including Jeffrey Farrow, Andrew Goldberg, and others.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for FY 2026 approved.
- Non-binding advisory vote on named executive officer compensation passed with 46.4M for, 0.6M against.
- Certificate of Amendment filed with Delaware Secretary of State on July 6, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/0001193125-26-296174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000119312526296174/achv-20260702.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-296174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer